A new review published this month (August, 2018) in the Journal Brain Sciences looked at the effectiveness of the ketogenic diet to treat adult epilepsy, adult malignant glioma (brain tumors), and Alzheimer’s disease. It was written by Tanya J. W. McDonald and Mackenzie C. Cervenka from the Department of Neurology, Johns Hopkins University School of Medicine. The review is titled "The Expanding Role of Ketogenic Diets in Adult Neurological Disorders." The aim of the review is to describe the evidence, preclinical and clinical, supporting Ketogenic Diet use in the management of adult epilepsy, adult malignant gliomas (brain tumors), and Alzheimer’s disease. Several randomized controlled trials support the use of Ketogenic Diets for the treatment of drug-resistant epilepsy and there is emerging evidence that these diets are also effective in treating refractory status epilepticus, malignant glioma and Alzheimer’s disease in adults.